A Diastereoselective Synthetic Approach towards the Synthesis of Berkeleylactone F and Its 4-epi-Derivative

Srijana Subba; Sumit Saha; Susanta Mandal

doi:10.1055/s-0040-1707305

SynOpen, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · SynOpen 2020; 04(04): 66-70
DOI: 10.1055/s-0040-1707305

letter

A Diastereoselective Synthetic Approach towards the Synthesis of Berkeleylactone F and Its 4-epi-Derivative

Srijana Subba

^aDepartment of Chemistry, National Institute of Technology Sikkim, Ravangla, South Sikkim 737139, India eMail: sumit.che@nitsikkim.ac.in

,

Sumit Saha ∗

^aDepartment of Chemistry, National Institute of Technology Sikkim, Ravangla, South Sikkim 737139, India eMail: sumit.che@nitsikkim.ac.in

,

Susanta Mandal

^bDepartment of Chemistry, Sikkim University, Tadong, Gangtok, Sikkim737102, India

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

A diastereoselective approach to the synthesis of berkeleylactone F is presented. The synthetic strategy is initiated with commercially available (R)-glycidol, 1,6-heptadiyne, and (R)-(+)-methyl lactate. The key feature of the approach is directional functionalization at both terminals of 1,6-heptadiyne.

Key words

macrolide - epoxide - ring opening - heptadiyne

Volltext

Referenzen

References and Notes

1a Laslop NV, Mankin AS. Trends Biochem. Sci. 2018; 43: 668
1b Kanoh S, Rubin BK. Clin. Microbiol. Rev. 2010; 23: 590
1c Przybylski P. Curr. Org. Chem. 2011; 15: 328
1d Gaynor M, Mankin AS. Curr. Top. Med. Chem. 2003; 3: 949

2a Feng Y, Yu Z, Zhang S, Xue Z, Huang J, Zhang H, Wan X, Chen A, Wang J. J. Agric. Food Chem. 2019; 67: 4782
2b Arsic B, Barber J, Čikoš A, Mladenovic M, Stankovic N, Novak P. Int. J. Antimicrob. Agents 2018; 51: 283
2c Cheng H, Huang H, Huang G. Eur. J. Med. Chem. 2018; 157: 925
2d Gao H, Huang G. Bioorg. Med. Chem. 2018; 26: 5578
2e Hajare AK, Ravikumar V, Khaleel S, Bhuniya D, Reddy DS. J. Org. Chem. 2011; 76: 963
2f Sugamata R, Sugawara A, Nagao T, Suzuki K, Hirose T, Yamamoto K, Oshima M, Kobayashi K, Sunazuka T, Akagawa KS, Omura S, Nakayama T, Suzuki K. J. Antibiot. 2014; 67: 213
2g Pan JJ, Wana X, Zhang SY, Huang J, Zhang H, Chen AL, Wang JD. Bioorg. Med. Chem. Lett. 2016; 26: 3376
2h Yadav JS, Das SK, Sabitha G. J. Org. Chem. 2012; 77: 11109

3a Michel KH, Demoarco PV, Nagarajan R. J. Antibiot. 1977; 30: 571
3b Chatterjee S, Subramanian M, Sharma A, Chattopadhyay S. Nat. Prod. Commun. 2018; 13: 1535
3c Chatterjee S, Sharma A, Chattopadhyay S. RSC Adv. 2014; 4: 42697
3d Reddy R, Suman D, Rao NN. Synlett 2012; 23: 272
3e Saidhareddya P, Shaw AK. RSC Adv. 2015; 5: 29114

4a Baoa J, Xua XY, Zhanga XY, Qi SH. Nat. Prod. Commun. 2013; 8: 1127
4b Talakokkula A, Baikadi K, Narsaiah AV. ARKIVOC 2019; 307
4c Jena BK, Reddy GS, Mohapatra DK. Org. Biomol. Chem. 2017; 15: 1863
4d Kandimalla SR, Reddy BV. S, Sabitha G. Synth. Commun. 2019; 49: 3191

5a Stierle AA, Stierle DB, Decato D, Priestley ND, Alverson JB, Hoody J, McGrath K, Klepacki D. J. Nat. Prod. 2017; 80: 1150
5b Ferko B, Zeman M, Formica M, Veselý S, Doháňošová J, Moncol J, Olejníková P, Berkeš D, Jakubec P, Dixon DJ, Caletková O. J. Org. Chem. 2019; 84: 7159
5c Reddy MS, Manikanta G, Krishna PR. Tetrahedron Lett. 2019; 60: 504

6a Sudina PR, Motati DR, Seema A. J. Nat. Prod. 2018; 81: 1399
6b Krishna PR, Prabhakar S, Ramana DV. Tetrahedron Lett. 2012; 53: 6843
6c Venkatraman L, Aldrich CC, Sherman DH, Fecik RA. J. Org. Chem. 2005; 70: 7267
6d Reddy CR, Suman D, Rao NN. Eur. J. Org. Chem. 2013; 3786
6e Avocetien KF, Li JJ, Liu X, Wang Y, Xing Y, O’Doherty GA. Org. Lett. 2016; 18: 4970

7a Jiang S, Liu ZH, Sheng G, Zeng BB, Cheng XG, Wu YL, Yao ZJ. J. Org. Chem. 2002; 67: 3404
7b Liau BB, Gnanadesikan V, Corey EJ. Org. Lett. 2008; 10: 1055
7c Maezaki N, Tominaga H, Kojima N, Yanai M, Urabe D, Tanaka T. Chem. Commun. 2004; 406
7d Maezaki N, Tominaga H, Kojima N, Yanai M, Urabe D, Ueki R, Tanaka T, Yamori T. Chem. Eur. J. 2005; 11: 6237
7e Falck JR, Wallukat G, Puli N, Goli M, Arnold C, Konkel A, Rothe M, Fischer R, Müller DN, Schunck WH. J. Med. Chem. 2011; 54: 4109
7f Liu HX, Huang GR, Zhang HM, Jiang S, Wu JR, Yao ZJ. ChemBioChem 2007; 8: 172
7g Jiang S, Li Y, Chen XG, Hu TS. Wu Y. L, Yao ZJ. Angew. Chem. Int. Ed. 2004; 43: 329
7h Zhao H, Gorman JS. T, Pagenkopf BL. Org. Lett. 2006; 8: 4379

8a González-Gil I, Zian D, Vázquez-Villa H, Hernández-Torres G, Martínez RF, Khiar-Fernández N, Rivera R, Kihara Y, Devesa I, Mathivanan S, Rosell del Valle C, Zambrana-Infantes E, Puigdomenech M, Cincilla G, Sanchez-Martinez M, Rodríguez de Fonseca F, Ferrer-Montiel AV, Chun J, López-Vales R, López-Rodríguez ML, Ortega-Gutiérrez S. J. Med. Chem. 2020; 63: 2372
8b Iio K, Sachimori S, Watanabe T, Fuwa H. Org. Lett. 2018; 20: 7851
8c Shiina I, Takasuna Y, Suzuki R, Oshiumi H, Komiyama Y, Hitomi S, Fukui H. Org. Lett. 2006; 8: 5279
8d Ramulu U, Ramesh D, Rajaram S, Reddy SP, Venkatesham K, Venkateswarlu Y. Tetrahedron: Asymmetry 2012; 23: 117

9a Léséleuc M, Godin E, Parisien-Collette S, Lévesque A, Collins SK. J. Org. Chem. 2016; 81: 6750
9b Shin D, Yang JE, Lee SB, Nho CW. Bioorg. Med. Chem. Lett. 2010; 20: 7549
9c Peňaška T, Koukal P, Kotora M. Eur. J. Org. Chem. 2018; 147
9d Reddy KS. N, Reddy AY, Sabitha G. Synthesis 2016; 48: 3812
9e Trost BM, Sieber JD, Qian W, Dhawan R, Ball ZT. Angew. Chem. Int. Ed. 2009; 48: 5478
9f Wu J, Wu Y, Jian Y, Zhang Y. Chin. J. Chem. 2009; 27: 13

10a Mengel A, Reiser O. Chem. Rev. 1999; 99: 1191
10b Guillarme S, Plé K, Banchet A, Liard A, Haudrechy A. Chem. Rev. 2006; 106: 2355

11a Beemelmanns C, Woznica A, Alegado RA, Cantley AM, King N, Clardy J. J. Am. Chem. Soc. 2014; 136: 10210
11b Porta A, Chiesa F, Quaroni M, Persico M, Moratti R, Zanoni G, Vidari G. Eur. J. Org. Chem. 2014; 2111

12a Sabitha G, Reddy CN, Gopal P, Yadav JS. Tetrahedron Lett. 2010; 51: 5736
12b Raghavan S, Yelleni MK. R. Tetrahedron 2017; 73: 4371
12c Rao JP, Rao BV. Tetrahedron: Asymmetry 2010; 21: 930
12d Kumar P, Naidu SV. J. Org. Chem. 2006; 71: 3935
12e Roush WR, Bennett CE, Roberts SE. J. Org. Chem. 2001; 66: 6389
12f Allu SR, Banne S, Jiang J, Qi N, Guo J, He Y. J. Org. Chem. 2019; 84: 7227
12g Kim D, Lee J, Shim PJ, Lim JI, Jo H, Kim S. J. Org. Chem. 2002; 67: 764
12h Reetz MT. Angew. Chem., Int. Ed. Engl. 1984; 23: 556

13 Synthesis of (S)-1-(Benzyloxy)deca-4,9-diyn-2-ol (4): To a solution of 1,6-heptadiyne (0.5 mL, 4.57 mmol, 1.0 equiv) in anhydrous THF (10 mL) at –78 °C under argon was added n-BuLi (4.6 mL, 4.6 mmol, 1.0 M in hexane 1 equiv). The resulting mixture was stirred for 30 min at this temperature and a solution of epoxide 3 (250 mg, 1.52 mmol, 0.33 equiv, dissolved in anhydrous THF, 5 mL) was added dropwise, followed by rapid addition of BF₃·Et₂O (freshly distilled, 0.6 mL, 6.66 mmol, 1.45 equiv) The reaction mixture was stirred for 1.5 h and then quenched with saturated aqueous NH₄Cl solution and extracted with Et₂O (3 × 20 mL). The combined organic extracts were washed with water and brine, dried over anhydrous Na₂SO₄ and concentrated under vacuum. The crude material was purified by column chromatography on silica gel (10% EtOAc in pet ether (PE)) to give pure alcohol 4 (0.88 g, 3.43 mmol 75%) as a yellow oily liquid. TLC: R_f 0.76 (10% EtOAc in PE). IR: 1096, 1428, 1633, 2115, 2946, 3453 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 1.71 (p, J = 7.0 Hz, 2 H), 1.99 (t, J = 2.6 Hz, 1 H), 2.28–2.33 (m, 4 H), 2.42–2.46 (m, 2 H), 3.52 (dd, J ₁,₂ = 3.92 Hz, J ₁,₃ = 9.52 Hz, 1 H), 3.61 (dd, J ₁,₂ = 6.68 Hz, J ₁,₃ = 9.52 Hz, 1 H), 3.92–3.98 (m, 1 H), 4.59 (s, 2 H), 7.30–7.40 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 17.5, 17.8, 23.9, 27.7, 68.8, 69.2, 72.9, 73.4, 76.4, 81.4, 83.5, 127.8, 128.3, 137.9. HRMS: m/z [M + Na]⁺ calcd for C₁₇H₂₀O₂Na: 279.1361; found: 279.1361.
14 Synthesis of (5S,14S,15R)-5-((Benzyloxy)methyl)-15,17,18,18-pentamethyl-2,4,16-trioxa-17-silanonadeca-7,12-diyn-14-ol (6): (R)-(+)-Methyl lactate (1.0 g, 9.60 mmol, 1 equiv), was dissolved in anhydrous DMF (5 mL), and imidazole (1.06 g, 15.57 mmol, 1.6 equiv) was added. The solution was cooled in an ice bath and TBSCl (1.45 g, 9.60 mmol, 1 equiv) was added slowly in portions. After the completion of addition, the ice bath was allowed to melt gradually overnight. After 18 h, the reaction mixture was diluted with water (3 mL) and hexanes (10 mL). The aqueous phase was separated and extracted with hexanes (60 mL), and the combined organic extract was washed with brine, dried over anhydrous Na₂SO₄, filtered, and concentrated by rotary evaporation to afford the TBS ether (1.6 g, 7.33 mmol, 76%) as a colorless liquid, which was used without purification. The above prepared TBS protected (R)-(+)-methyl lactate (1.00 g, 4.58 mmol, 1 equiv), in hexanes (20 mL), was cooled to –78 °C, DIBAL-H (4.7 mL, 1.0 M in hexanes, 4.7 mmol, 1.0 equiv) was added dropwise and the mixture was stirred for 45 minutes at –78 °C. The reaction mixture was then quenched by addition of MeOH (1.0 mL) and stirred for 15 min at –78 °C. The cold solution was transferred to a round-bottom flask containing saturated aqueous Rochelle salt (10 mL) and the resulting mixture was vigorously stirred for 30 min. The aqueous phase was separated and extracted with hexanes, and the combined organic extracts were washed with brine, dried over anhydrous Na₂SO₄, filtered, and concentrated to afford the aldehyde (0.70 g, 3.66 mmol, 80%) as a colorless liquid. To a solution of compound 5 (0.90 g, 3.0 mmol, 1 equiv) in anhydrous THF (15 mL), n-BuLi (.3.0 mL, 3.0 mmol, 1 M in THF, 1 equiv) was added dropwise at –78 °C. The solution was stirred for 30 min at the same temperature and then freshly prepared aldehyde was added to the reaction mixture dropwise (0.70 g, 3.66 mmol, 1.2 equiv over 30 mins) and the mixture was stirred for 2.5 h. The reaction mixture was quenched with saturated aqueous NH₄Cl and the organic phase was separated and evaporated under reduced pressure. The aqueous layer was extracted with EtOAc and the organic extract was washed with brine, dried over anhydrous Na₂SO₄, filtered and concentrated by rotary evaporation. Column chromatographic purification (10% EtOAc in PE) of the resultant crude residue provided pure alcohol 6 (1.20 g, 2.45 mmol, 80%) as a pale-yellow liquid. TLC: R_f 0.67 (5% EtOAc in PE). IR: 1252, 1494, 1628, 2245, 2985, 3470 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 0.11 (s, 3 H), 0.12 (s, 3 H), 0.92 (s, 9 H), 1.24 (d, J = 6.24 Hz, 3 H), 1.59 (brs, 1 H), 1.68 (p, J = 6.43 Hz, 2 H), 2.24–2.37 (m, 4 H), 2.48–2.53 (m, 2 H), 3.41 (s, 3 H), 3.62–3.64 (m, 2 H), 3.86–3.94 (m, 2 H), 4.28 (m, 1 H), 4.59 (s, 2 H), 4.77 (s, 2 H), 7.30–7.37 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = –4.7, –4.4, 17.9, 22.2, 25.8, 27.9, 55.5, 67.1, 71.2, 71.6, 73.4, 74.8, 78.6, 80.9, 85.8, 95.9, 127.6, 127.6, 128.4S, 138.2. HRMS: m/z [M + Na]⁺ calcd for C₂₈H₄₄O₅SiNa: 511.7212; found: 511.7211.

Zusatzmaterial

Supporting Information